Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Methods of Documentation VI: Case Management Model

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Introduction To Health Care Delivery System

Introduction To Health Care Delivery System

The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011.

Health affairs (Project Hope)·2014

Same author

Analyst: pharmacists have nothing to complain about.

Managed care (Langhorne, Pa.)·2013

Same author

Managing wholesaler agreements in the fee-for-service era.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2007

Same journal

Findings from the 2025 AMCP Foundation Symposium: Health Optimization 2.0.

Journal of managed care & specialty pharmacy·2026

Same journal

AMCP Market Insights: Managed care considerations in Barth syndrome.

Journal of managed care & specialty pharmacy·2026

Same journal

Association between comorbid depression, antidepressant adherence, and disease-modifying therapy adherence among Texas Medicaid patients with sickle cell disease.

Journal of managed care & specialty pharmacy·2026

Same journal

Incremental health care resource utilization, costs, and predictors of high costs in generalized myasthenia gravis.

Journal of managed care & specialty pharmacy·2026

Same journal

Real-world switching and switch-back patterns among patients transitioning from adalimumab to biosimilars in the United States (February 2023 to August 2025).

Journal of managed care & specialty pharmacy·2026

Same journal

The effectiveness and value of B-cell-directed therapies for the treatment of immunoglobulin A nephropathy.

Journal of managed care & specialty pharmacy·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 23, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

Challenges for Managed Care from 340B Contract Pharmacies.

¹1 President, Pembroke Consulting, Philadelphia, Pennsylvania.

Journal of Managed Care & Specialty Pharmacy

|March 23, 2016

Summary

This summary is machine-generated.

The 340B Drug Pricing Program

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Experiment Videos

Last Updated: Mar 23, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

Health policy
Pharmacy practice
Health economics

Background:

The federal 340B Drug Pricing Program has seen significant expansion.
Providers increasingly use contract pharmacies to extend 340B pricing benefits.
In 2014, 25% of U.S. pharmacy locations served as contract pharmacies for 340B entities.

Purpose of the Study:

To analyze the impact of 340B program growth on managed care pharmacy.
To discuss the effects on formulary rebates, prescription profits, and pharmacy networks.
To highlight the need for managed care engagement and policy proposals.

Main Methods:

This is a commentary discussing observed trends and potential impacts.
Analysis of the effects of 340B expansion on managed care pharmacy practices.
Review of the implications for formulary rebates, profits, and generic dispensing rates.

Main Results:

340B growth impacts managed care pharmacy through formulary rebates and profits.
Disruption of retail pharmacy networks and reduced generic dispensing rates are observed.
Contract pharmacy utilization has become widespread.

Conclusions:

Managed care pharmacy faces challenges due to 340B program expansion.
Increased engagement and policy proposals are needed from managed care organizations.
Objective research on the 340B program's costs and benefits is urgently required.